Playing from staycurrentmd
35 views 0 likes

StayCurrentMD

GCMD Space · View profile →

Indocyanine green is a sensitive adjunct in the identification and surgical management of local and metastatic hepatoblastoma

Video Published 2026-01-23

Timestops (3)

0:00
Are you actually seeing all the hepatoblastoma during your r…
Are you actually seeing all the hepatoblastoma during your resection? Hi, I'm Doctor Sophia Schermerhorn from Cincinnati…
0:27
Importantly
Importantly, in a meaningful number of cases, ICG was able to detect tumor deposits that were not visible, palpable, or …
0:55
Key takeaway is that ICG is a valuable tool that can help in…
Key takeaway is that ICG is a valuable tool that can help increase confidence in achieving a complete resection for both…

Topic Overview

A single-institution retrospective review examining indocyanine green (ICG) fluorescence imaging in hepatoblastoma surgery. The study found ICG demonstrated approximately 90% sensitivity for detecting hepatoblastoma in both liver resections and pulmonary metastasectomies, identifying tumor deposits not visible by palpation or preoperative imaging in a meaningful number of cases. Specificity was lower than sensitivity, with false positives often representing vascular changes or inflammation, though no adverse outcomes resulted from additional resections guided by ICG.

Key Takeaways

  • ICG fluorescence imaging achieved ~90% sensitivity for detecting hepatoblastoma in liver resections and pulmonary metastasectomies. (0:12)
  • ICG identified tumor deposits not visible by palpation or preoperative imaging in a meaningful number of hepatoblastoma cases. (0:27)
  • False-positive ICG signals often represented vascular changes or inflammation, but caused no adverse outcomes from additional resection. (0:39)
  • ICG was effective across surgical approaches (open/MIS) and disease stages (primary/relapse) in hepatoblastoma management. (0:50)

Inside this episode

Kai, the Library's AI content creator, listened to this episode and mapped who's speaking, the chapters, key claims, and cases. Every item links to the exact moment in the recording.

AI-enriched

Who's speaking

  • Dr. Sophia Schermerhorn — guest

Chapters

  • 0:00ICG fluorescence imaging in hepatoblastoma surgery — Dr. Schermerhorn presents findings on ICG use in hepatoblastoma resection, covering study design, sensitivity and specificity results, clinical utility in detecting occult lesions, and applicability across surgical approaches and disease stages.

Key claims

  • 0:12This is a single institution retrospective review of patients who received ICG prior to either pulmonary metastatectomy or liver resection for hepatoblastoma — Dr. Sophia Schermerhorn
  • 0:22ICG was highly sensitive for detecting hepatoblastoma, about 90% — Dr. Sophia Schermerhorn
  • 0:27In a meaningful number of cases, ICG was able to detect tumor deposits that were not visible, palpable, or detectable on preoperative imaging — Dr. Sophia Schermerhorn
  • 0:39Specificity was lower than sensitivity with false positives — Dr. Sophia Schermerhorn
  • 0:43False positives often represented vascular changes or inflammation — Dr. Sophia Schermerhorn
  • 0:46There were no adverse outcomes associated with any of the additional resections guided by ICG — Dr. Sophia Schermerhorn
  • 0:50ICG was effective in both open and minimally invasive surgery — Dr. Sophia Schermerhorn
  • 0:50ICG was effective in both relapse and primary disease — Dr. Sophia Schermerhorn
This episode was analyzed and enriched by Kai, the Library's AI content creator. Every item links to the moment it comes from — click a timestamp to listen in context.

Keywords

hepatoblastoma metastatic hepatoblastoma pulmonary metastases pulmonary metastatectomy liver resection minimally invasive surgery open surgery indocyanine green ICG Cincinnati Children's

Hashtags

#Hepatoblastoma #PediatricOncology #LiverSurgery #IndocyanineGreen #SurgicalImaging #FluorescenceGuidedSurgery #SurgicalInnovation

Transcript

Comments

Loading comments…